Kellie Chase Berg
Medtronic (United States)(US)
Publications by Year
Research Areas
Pelvic floor disorders treatments, Urinary Bladder and Prostate Research, Cardiac pacing and defibrillation studies, Cardiac Arrhythmias and Treatments, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6‐months in subjects with mild symptoms of overactive bladder(2014)202 cited
- → Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation(2017)174 cited
- → Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder(2014)97 cited
- → Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: Primary results of the Rhythm ID Going Head to Head Trial(2011)66 cited
- → Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy(2009)36 cited
- → A Randomized Trial of the Effect of Automated Ventricular Capture on Device Longevity and Threshold Measurement in Pacemaker Patients(2008)23 cited
- → Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: Results from the INTRINSIC RV trial(2011)22 cited
- → Clinical and Electrical Performance of Expanded Polytetrafluoroethylene‐Covered Defibrillator Leads in Comparison to Traditional Leads(2007)11 cited
- → Baseline symptom severity and therapeutic success in a large prospective trial of sacral neuromodulation therapy for overactive bladder patients(2018)8 cited
- → Does change in device detected frequency of non-sustained or diverted episodes serve as a marker for inappropriate shock therapy? Analyses from the INTRINSIC RV and ALTITUDE-REDUCES Trials(2014)1 cited